Literature DB >> 21217150

Mode of DNA binding by SopA protein of Escherichia coli F plasmid.

Masahiko Komai1, Masafumi Umino, Ryo Hanai.   

Abstract

The binding of SopA to the promoter region of its own gene, in which four copies of SopA's recognition sequence, 5'-CTTTGC-3', are arrayed asymmetrically, was examined in vitro. Titration using electrophoretic mobility shift assay showed that the stoichiometry of SopA protomers to the promoter-region DNA is 4 and that the binding is highly co-operative. The co-operativity was corroborated by EMSA and DNase I footprinting for a number of mutant DNA fragments in which 5'-CTTTGC-3' was changed to 5'-CTTACG-3'. EMSA in the style of circular permutation showed that SopA bends DNA. Mutation at either outermost binding site had a different effect on DNA bending by SopA, reflecting the asymmetry in the arrangement of the binding sites, for which the results of DNase I footprinting were in agreement. Gel filtration chromatography and analytical ultracentrifugation of free SopA showed that the protein can exist as a monomer and oligomers in the absence of ATP. Hence, the results indicate that the co-operativity in SopA's DNA binding is based on its intrinsic protein-protein interaction modified by DNA interaction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21217150     DOI: 10.1093/jb/mvq151

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

Review 1.  Microcompartments and protein machines in prokaryotes.

Authors:  Milton H Saier
Journal:  J Mol Microbiol Biotechnol       Date:  2013-08-05

Review 2.  Catching a Walker in the Act-DNA Partitioning by ParA Family of Proteins.

Authors:  Dipika Mishra; Ramanujam Srinivasan
Journal:  Front Microbiol       Date:  2022-05-26       Impact factor: 6.064

3.  Three ParA Dimers Cooperatively Assemble on Type Ia Partition Promoters.

Authors:  François Boudsocq; Maya Salhi; Sophie Barbe; Jean-Yves Bouet
Journal:  Genes (Basel)       Date:  2021-08-28       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.